We therefore measured the activities of matrix metalloproteinases (MMP2/9) and cathepsin D — proteases with known roles in endothelial injury (50) — and found that MMP (Supplemental Figure 2A) and cathepsin D (Supplemental Figure 2B) activities are significantly increased in patients with COVID-19 compared with healthy donors. This evidence concerns the gene CTSD and COVID-19.